{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T22:27:02Z","timestamp":1774564022309,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"9252","license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[2001,1]]},"DOI":"10.1016\/s0140-6736(00)03611-4","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T19:14:33Z","timestamp":1027624473000},"page":"257-261","source":"Crossref","is-referenced-by-count":150,"title":["Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial"],"prefix":"10.1016","volume":"357","author":[{"given":"Anne E","family":"Tattersfield","sequence":"first","affiliation":[]},{"given":"Claes-G\u00f6ran","family":"L\u00f6fdahl","sequence":"additional","affiliation":[]},{"given":"Dirkje S","family":"Postma","sequence":"additional","affiliation":[]},{"given":"Arne","family":"Eivindson","sequence":"additional","affiliation":[]},{"given":"Ad GM","family":"Schreurs","sequence":"additional","affiliation":[]},{"given":"Antonis","family":"Rasidakis","sequence":"additional","affiliation":[]},{"given":"Tommy","family":"Ekstr\u00f6m","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(00)03611-4_bib1","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199711133372001","article-title":"Effect of inhaled formoterol and budesonide on exacerbations of asthma","volume":"337","author":"Pauwels","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(00)03611-4_bib2","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/bmj.314.7092.1441","article-title":"Effect of long term treatment with salmeterol on asthma control: a double-blind, randomised crossover study","volume":"314","author":"Wilding","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/S0140-6736(00)03611-4_bib3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/thx.52.6.535","article-title":"Effects of the long acting \u03b2 agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids","volume":"52","author":"Van der Molen","year":"1997","journal-title":"Thorax"},{"key":"10.1016\/S0140-6736(00)03611-4_bib4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1164\/ajrccm.151.1.7812574","article-title":"Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol","volume":"151","author":"Juniper","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/S0140-6736(00)03611-4_bib5","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1183\/09031936.99.14510389","article-title":"Asthma quality of life during one year of treatment with budesonide with or without formoterol","volume":"14","author":"Juniper","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/S0140-6736(00)03611-4_bib6","series-title":"National Heart Lung and Blood Institute, NHLBI\/WHO Workshop Report: the global strategy for asthma management and prevention. Publication No. 95-3659","year":"1995"},{"key":"10.1016\/S0140-6736(00)03611-4_bib7","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1742-1241.1995.tb09989.x","article-title":"Onset of action of eformoterol by dry powder inhaler; objective and subjective measures","volume":"49","author":"Maesen","year":"1995","journal-title":"Br J Clin Pract"},{"key":"10.1016\/S0140-6736(00)03611-4_bib8","first-page":"1684","article-title":"A direct comparison of the time of onset of action between inhaled formoterol and salmeterol","volume":"9","author":"Linsen","year":"1996","journal-title":"Eur Respir J"},{"key":"10.1016\/S0140-6736(00)03611-4_bib9","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1183\/09031936.97.10112489","article-title":"Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency","volume":"10","author":"Palmqvist","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1016\/S0140-6736(00)03611-4_bib10","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0954-6111(98)90348-1","article-title":"Onset and duration of action of single doses of formoterol inhaled via Turbuhaler","volume":"92","author":"Ringdal","year":"1998","journal-title":"Respir Med"},{"key":"10.1016\/S0140-6736(00)03611-4_bib11","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1034\/j.1399-3003.1999.13e10.x","article-title":"Comparison of formoterol, salbutamol and salmeterol in methacholine-induced severe bronchoconstriction","volume":"13","author":"Politiek","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/S0140-6736(00)03611-4_bib12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1183\/09031936.98.12030573","article-title":"Tolerability to high doses of formoterol and terbutaline via Turbuhaler for 3 days in stable asthmatic patients","volume":"12","author":"T\u00f6tterman","year":"1998","journal-title":"Eur Respir Dis"},{"key":"10.1016\/S0140-6736(00)03611-4_bib13","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1183\/09031936.93.06020204","article-title":"A comparison of the cardiovascular and metabolic effects of formoterol, salbutamol and fenoterol","volume":"6","author":"Bremner","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1016\/S0140-6736(00)03611-4_bib14","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/thorax.55.8.650","article-title":"Systemic effects of formoterol and salbutamol: a dose-response comparison in healthy subjects","volume":"55","author":"Guhan","year":"2000","journal-title":"Thorax"},{"issue":"suppl 16","key":"10.1016\/S0140-6736(00)03611-4_bib15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1183\/09041950.005s1693","article-title":"Lung volumes and forced ventilatory flows: report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal: official statement of the European Respiratory Society","volume":"6","author":"Quanjer","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1016\/S0140-6736(00)03611-4_bib16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1164\/ajrccm\/136.1.225","article-title":"Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma","volume":"136","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/S0140-6736(00)03611-4_bib17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1183\/09031936.93.02040325","article-title":"Formoterol, a new long-acting bronchodilator for inhalation","volume":"2","author":"Arvidsson","year":"1989","journal-title":"Eur Respir J"},{"key":"10.1016\/S0140-6736(00)03611-4_bib18","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1183\/09031936.93.04101168","article-title":"Inhaled formoterol during one year in asthma: a comparison with salbutamol","volume":"4","author":"Arvidsson","year":"1991","journal-title":"Eur Respir J"},{"key":"10.1016\/S0140-6736(00)03611-4_bib19","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1378\/chest.101.4.1019","article-title":"Formoterol a new long acting beta-2 agonist, inhaled twice daily, in stable asthmatic subjects","volume":"101","author":"Midgren","year":"1992","journal-title":"Chest"},{"key":"10.1016\/S0140-6736(00)03611-4_bib20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/thx.45.4.259","article-title":"Formoterol, a new long acting beta2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma","volume":"45","author":"Wallin","year":"1990","journal-title":"Thorax"},{"key":"10.1016\/S0140-6736(00)03611-4_bib21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1476-5381.1993.tb13855.x","article-title":"Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung","volume":"110","author":"Whelan","year":"1993","journal-title":"Br J Pharmacol"},{"key":"10.1016\/S0140-6736(00)03611-4_bib22","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/ajrccm\/144.4.788","article-title":"Long duration and high potency of antiexudative effects of formoterol in guinea-pig tracheobronchial airways","volume":"144","author":"Erjef\u00e4lt","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/S0140-6736(00)03611-4_bib23","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1476-5381.1992.tb09059.x","article-title":"Formoterol and salbutamol inhibit bradykinin- and histamine-induced airway microvascular leakage in guinea-pig","volume":"105","author":"Advenier","year":"1992","journal-title":"Br J Pharmacol"},{"key":"10.1016\/S0140-6736(00)03611-4_bib24","first-page":"L461","article-title":"The beta2-adrenergic receptor agonist formoterol reduces microvascular leakage by inhibiting endothelial gap formation","volume":"266","author":"Baluk","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/S0140-6736(00)03611-4_bib25","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1476-5381.1994.tb17047.x","article-title":"The interaction between salmeterol and beta2-adrenoceptor agonists with higher efficacy on guinea-pig trachea and human bronchus in vitro","volume":"113","author":"K\u00e4llstr\u00f6m","year":"1994","journal-title":"Br J Pharmacol"},{"key":"10.1016\/S0140-6736(00)03611-4_bib26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1164\/ajrccm.159.1.9801007","article-title":"The effects of regular inhaled formoterol, budesonide and placebo on mucosal inflammation and clinical indices in mild asthma","volume":"159","author":"Wallin","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/S0140-6736(00)03611-4_bib27","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/thx.53.12.1010","article-title":"Effects of formoterol on histamine-induced plasma exudation in induced sputum from normal subjects","volume":"53","author":"Greiff","year":"1998","journal-title":"Thorax"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673600036114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673600036114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T05:16:34Z","timestamp":1704086194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673600036114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":27,"journal-issue":{"issue":"9252","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["S0140673600036114"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(00)03611-4","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}